-
Signature
-
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
-
Stock symbol
-
CYTK
-
Transactions as of
-
Dec 27, 2023
-
Transactions value $
-
-$691,600
-
Form type
-
4
-
Date filed
-
12/27/2023, 04:11 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$22.2K |
+5K |
+26.81% |
$4.44* |
23.7K |
Dec 27, 2023 |
Direct |
F1 |
| transaction |
CYTK |
Common Stock |
Sale |
-$368K |
-5K |
-21.14% |
$73.60 |
18.7K |
Dec 27, 2023 |
Direct |
F1 |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$22.2K |
+5K |
+26.81% |
$4.44* |
23.7K |
Dec 27, 2023 |
Direct |
F1 |
| transaction |
CYTK |
Common Stock |
Sale |
-$368K |
-5K |
-21.14% |
$73.60 |
18.7K |
Dec 27, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-50% |
$0.00 |
5K |
Dec 27, 2023 |
Common Stock |
5K |
$4.44 |
Direct |
F1, F2 |
| transaction |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-100% |
$0.00* |
0 |
Dec 27, 2023 |
Common Stock |
5K |
$4.44 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: